Minoxidil
Minoxidil is a vasodilator repurposed as the leading topical hair-loss treatment, also used off-label at low oral doses. It is not an anti-androgen but is the standard companion to 5ARIs and AR antagonists, promoting hair growth by prolonging the follicle growth phase. Oral use adds cardiovascular and fluid-retention considerations.
01 Overview
Originally an oral antihypertensive, minoxidil's hair-growth side effect led to topical formulations (Rogaine) approved for androgenetic alopecia in both sexes. In recent years low-dose oral minoxidil (LDOM) has become popular off-label for greater convenience and efficacy.
Topical minoxidil is well tolerated aside from local irritation and unwanted facial hair; oral use requires attention to blood pressure, heart rate, and fluid retention. It is mechanistically complementary to DHT-blocking drugs and often combined with them.
02 Mechanism
As the active sulfated metabolite, minoxidil opens ATP-sensitive potassium channels and acts as a vasodilator, prolonging the anagen (growth) phase of hair follicles and enlarging miniaturised follicles; it does not affect androgens.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Low-dose oral (off-label) | 0.625–5 mg/day | Oral | LDOM 0.625-5 mg/day off-label for hair loss |
| Topical | 2–5 %/day | Transdermal | 5% foam/solution once or twice daily to the scalp |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Increased hair growthIncreases hair count and thickness in androgenetic alopecia; prolongs the growth phase. | Significant vs placebo | Clinical | |
| Synergy with anti-androgensComplements finasteride/dutasteride by acting through a non-hormonal mechanism. | Additive | Clinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Unwanted facial/body hair (hypertrichosis)Excess hair growth on the face or elsewhere, more common with oral use. | Mild | Common | Clinical | |
| Fluid retention / edema (oral)Ankle swelling and fluid retention, mainly with oral dosing. | Moderate | Uncommon | Clinical | |
| Tachycardia / palpitations (oral)Increased heart rate or palpitations with oral use. | Moderate | Uncommon | Clinical |